Sign In
Buy CVM
$1.22
-0.160 (-11.59%)
At Close: Jul 13, 2026
CEL-SCI Announces Common Stock Offering, Size Not Disclosed
12:00am, Monday, 23'rd Dec 2019Hedge Funds Are Buying CEL-SCI Corporation (CVM)
08:28pm, Friday, 20'th Dec 2019
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking. Hedge funds underperform because their net exposure in only 40-70% and they charge exo
CEL-SCI Corporation to Present at The LD Micro Main Event (XII)
02:00pm, Friday, 06'th Dec 2019
VIENNA, VA / ACCESSWIRE / December 6, 2019 / CEL-SCI Corporation (NYSE American:CVM), a Phase 3 cancer immunotherapy company, today announced that it will be presenting at the 12th annual LD Micro Mai
CEL-SCI Corporation to Present at The LD Micro Main Event (XII)
12:00am, Friday, 06'th Dec 2019Cel-Sci is publicly upbeat about a cancer drug. Privately it tried to sell stock
06:10pm, Thursday, 24'th Oct 2019
Trying to sell stock now on the down-low reveals a harsher truth about Cel-Sci and is an ominous tell for the fate of its immunotherapy.
'Cel-Sci is publicly upbeat about its cancer drug. Privately it's trying to sell stock' -STAT News' Adam Feuerstein
12:00am, Thursday, 24'th Oct 2019Bearish CEL-SCI Article Ignored Scientific Evidence And Misinterpreted Multikine's Clinical Trial Design
12:00am, Monday, 14'th Oct 2019Cel-Sci hasn't been upfront on its cancer drug. Time for some truth-telling
08:01pm, Monday, 07'th Oct 2019
Some myths and facts about a Phase 3 clinical trial involving an immunotherapy for head and neck cancer owned by the tiny biotech Cel-Sci.
